Investor Relations

SEC Filings

Document Details

Filing Date
Sep 28, 2023
Document Date
Sep 28, 2023
Form Description
Filing by person(s) reporting owned shares of common stock in a public company >5%
Filing Group
Other
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.